Hidradenitis suppurativa

R Sabat, GBE Jemec, Ł Matusiak, AB Kimball… - Nature Reviews …, 2020 - nature.com
Hidradenitis suppurativa (HS; also designated as acne inversa) is a chronic inflammatory
disorder, which affects the intertriginous skin and is associated with numerous systemic …

Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life

TV Nguyen, G Damiani, LAV Orenstein… - Journal of the …, 2021 - Wiley Online Library
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that severely impairs
patients' quality of life. It is characterized by recurrent painful nodules, abscesses and …

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised …

AB Kimball, GBE Jemec, A Alavi, Z Reguiai, AB Gottlieb… - The Lancet, 2023 - thelancet.com
Background Few therapeutic options are available for patients with moderate-to-severe
hidradenitis suppurativa. We aimed to assess the efficacy of secukinumab in patients with …

Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis

SR Goldburg, BE Strober, MJ Payette - Journal of the American Academy …, 2020 - Elsevier
Hidradenitis suppurativa (HS) is an inflammatory disorder that is characterized by chronic
deep-seated nodules, abscesses, fistulae, sinus tracts, and scars in the axilla, inguinal area …

Unmet medical needs in chronic, non-communicable inflammatory skin diseases

H Ujiie, D Rosmarin, MP Schön, S Ständer… - Frontiers in …, 2022 - frontiersin.org
An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

[HTML][HTML] Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

A Garg, N Malviya, A Strunk, S Wright, A Alavi… - Journal of the American …, 2022 - Elsevier
Background Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to
poor health, impaired life quality, and mortality risk. Objective To provide evidence-based …

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

A Garg, E Neuren, D Cha, JS Kirby, JR Ingram… - Journal of the American …, 2020 - Elsevier
Background A needs assessment for patients with hidradenitis suppurativa (HS) will support
advancements in multidisciplinary care, treatment, research, advocacy, and philanthropy …

Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - jamanetwork.com
Importance Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high
burden for patients and limited existing therapeutic options. Objective To evaluate the …

The epidemiology of hidradenitis suppurativa

JR Ingram - British Journal of Dermatology, 2020 - academic.oup.com
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease defined clinically by
multiple, painful inflammatory lesions occurring predominantly in flexural sites. Onset is …

British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018

JR Ingram, F Collier, D Brown, T Burton… - British Journal of …, 2019 - academic.oup.com
British Association of Dermatologists guidelines for the management of hidradenitis
suppurativa (acne inversa) 2018 | British Journal of Dermatology | Oxford Academic Skip to …